Bleeding and Clotting Disorders
Protocol:1321.7
Condition or Disease: Hemorrhage
Study Type: Interventional (Clinical Trial)
Status: Open for enrollment
Study Title: Single dose, open label, uncontrolled, safety trial of intravenous administration of idarucizumab to paediatric patients enrolled from ongoing phase IIb/III clinical trials with dabigatran etexilate for the treatment and secondary prevention of venous thromboembolism.
Principal I investigator: Alan Ikeda, MD
More Info: //clinicaltrials.gov/ct2/show/NCT02815670
